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Background: Attention Deficit Hyperactivity disorder (ADHD) is one of the most common 
and challenging childhood neurobehavioral disorders. ADHD is known to negatively impact 
children, their families, and their community. About one-third to one-half of patients with 
ADHD will have persistent symptoms into adulthood. The prevalence in the United States 
is estimated at 5–11%, representing 6.4 million children nationwide. The variability in the 
prevalence of ADHD worldwide and within the US may be due to the wide range of factors 
that affect accurate assessment of children and youth. Because of these obstacles to 
assessment, ADHD is under-diagnosed, misdiagnosed, and undertreated.
Objectives: We examined factors associated with making and receiving the diagnosis 
of ADHD. We sought to review the consequences of a lack of diagnosis and treatment 
for ADHD on children’s and adolescent’s lives and how their families and the community 
may be involved in these consequences.
Methods: We reviewed scientific articles looking for factors that impact the identification 
and diagnosis of ADHD and articles that demonstrate naturalistic outcomes of diagnosis 
and treatment. The data bases PubMed and Google scholar were searched from the year 
1995 to 2015 using the search terms “ADHD, diagnosis, outcomes.” We then reviewed 
abstracts and reference lists within those articles to rule out or rule in these or other articles.
Results: Multiple factors have significant impact in the identification and diagnosis of 
ADHD including parents, healthcare providers, teachers, and aspects of the environ-
ment. Only a few studies detailed the impact of not diagnosing ADHD, with unclear 
consequences independent of treatment. A more significant number of studies have 
examined the impact of untreated ADHD. The experience around receiving a diagnosis 
described by individuals with ADHD provides some additional insights.
Conclusion: ADHD diagnosis is influenced by perceptions of many different members 
of a child’s community. A lack of clear understanding of ADHD and the importance of its 
diagnosis and treatment still exists among many members of the community including 
parents, teachers, and healthcare providers. More basic and clinical research will improve 
methods of diagnosis and information dissemination. Even before further advancements 
in science, strong partnerships between clinicians and patients with ADHD may be the 
best way to reduce the negative impacts of this disorder.
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iNTRODUCTiON
Faced with controversies from the medical field, parents, and 
educational authorities, the diagnosis and treatment of ADHD 
has continued to be a source of debate (1–3). Studies have differed 
on their estimation for the prevalence of ADHD (4). Some have 
suggested that ADHD is an over-diagnosed and over-treated 
condition as the parent reported diagnosis of ADHD has risen 
from 6.9% in 1997 to 7.8% in 2003, to 9.5% in 2007, and to 11% 
in 2011 (5, 6). On the other hand, many child psychiatrists and 
healthcare providers believe that ADHD is an underdiagnosed 
and undertreated condition, with many cases being missed for a 
variety of reasons. In this review, we discuss factors that interfere 
with adequate diagnosis of ADHD; many aspects of a child or 
youth’s life contribute to missed or delayed diagnosis. We also 
review the consequences of a missed or delayed ADHD diagnosis. 
Many lines of evidence demonstrate that a failure to diagnose 
ADHD prevents children and their families from getting the 
assistance they need to achieve their full potential in academic 
and psychosocial settings (7). Other studies suggest that untreated 
behavioral problems pose significant sociocultural, academic, 
employment, relationship, and life coping skill deficit (8). We 
also review whether the presence of an ADHD diagnosis itself, 
irrespective of receiving treatment, has consequences. Included 
in this, we consider how the patient experience of receiving an 
ADHD diagnosis may have both negative and positive compo-
nents but is certainly a critical component when considering the 
broader impacts of ADHD.
CHALLeNGeS AFFeCTiNG ReCOGNiTiON 
AND DiAGNOSiS OF ADHD
The American Academy of Pediatrics and other groups that care 
for children suggest that ADHD be screened for and diagnosed 
as early as the preschool years (9) to afford those affected the 
ability to achieve their full potential in school or at home (7). 
Many factors intrinsic to children themselves have informed 
these guidelines, but many factors outside of the child also play a 
role in how diagnosis occurs. Multiple factors may influence pres-
entation to providers and therefore also the timing of diagnosis 
and treatment of ADHD including the role of parents, aspects of 
the medical system, school-based factors, and those intrinsic to 
children (10).
Parental Role
Parents play a major role in early recognition of behavioral 
problems in their children which may prompt them to seek 
medical help (10). Parental perception of whether ADHD is a 
neurobehavioral disorder that requires medical management 
can affect their decision to seek medical help or be accepting of 
medical advice and treatment once evaluated. A range of beliefs 
about contributions to child behavior lead parents not to seek 
assessment for ADHD including dietary factors (11), limitations 
of the educational setting (12), not perceiving child behavior 
as a burden (1), and having a higher threshold for behavioral 
tolerance before seeking assessment (13). Factors other than 
conceptualizations about the origin of behavioral differences 
may also influence parents in whether and when they seek ADHD 
assessment. The motivation and ability to seek assessment may be 
affected by psychosocial stressors like financial difficulties (10), 
having other children, and whether their child has inattentive 
ADHD, which can be perceived by parents as less problematic 
(1). In the US, parental income and type of health insurance can 
strongly influence the timing of the diagnosis of ADHD (10, 
14) as the use of specialist services for evaluations of their child 
can be a financial burden (1). Parents’ own life course may also 
play a role in their perception of ADHD as a problem that needs 
assessment (15). A study of 324 children who participated in the 
Multimodal Treatment Study of Children with ADHD (MTA) 
determined that agreement and disagreement in ratings of moth-
ers and fathers were attributable to parental stress (16). This may 
represent an important factor in why ADHD comes to attention 
in some children and not in others, but is also an important factor 
for clinicians to consider when collecting data from parents about 
symptomology in their child.
Parental exposure to negative information about ADHD, usu-
ally from non-healthcare professionals or social media (17), can 
also delay the process of the diagnosis and treatment of ADHD 
(18). Some parents report that they believe that ADHD diagnosis 
is a means to “create business” for private practice physicians 
and/or that companies generate revenue from unnecessary use of 
pharmacologic treatments (13). Such findings speak to the need 
for community and parental education regarding the symptoms 
of and help available for ADHD in attempts to increase the 
timely diagnosis and treatment of ADHD. Higher rates of parents 
describing ADHD symptoms in medical terms have been associ-
ated with increased receipt of medical service (1).
Parents from different cultural and ethnical backgrounds 
may have different views and perceptions of behavioral norms 
and when to consider behavior inappropriate or indicative of a 
clinical disorder such as ADHD (19). The rate of ADHD in the US 
pediatric population based on parental report has been found to 
be lower in Hispanics and African Americans than in Caucasians 
(2, 20) and the prevalence among Hispanics were half that of 
non-Hispanics (6). An awareness of differing cultural beliefs and 
belief systems on the part of health care professionals is crucial 
to unify parental beliefs, clinical psychoeducation, and treatment 
recommendations (11). Given the diverse population of children 
in the US (19), different interpretations or explanations for the 
symptoms of ADHD exist among different cultural backgrounds 
(11, 21). In many immigrant communities, a psychiatric diagno-
sis of ADHD is associated with isolation and social exclusion (19). 
In some cultures, hyperactivity and/or impulsivity in boys can be 
endorsed as typical by parents and viewed as gender preferred 
behavior (22).
The level of trust and communication between parents and 
teachers also has a significant impact in the early diagnosis 
of ADHD (12). Given that the majority of the children in the 
US attend kindergarten by the age of 5 years and many others 
attend daycares and preschools earlier; effective communication 
between concerned teachers and parents is an important factor 
in early and appropriate identification of children at risk (12). 
Mistrust between parents and teachers can have a negative impact 
on seeking an assessment for an ADHD diagnosis (11). For this 
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and other reasons, it is important that teachers and educational 
authorities build strong and trusting relationships with parents. 
This allows information to be shared about a child’s functioning 
and any concerns about symptoms or impairment. Additionally, 
parents of children with ADHD have a higher probability of 
having the diagnosis themselves (23) and a lack of diagnosis in 
parents can lead to increased risk of family conflicts and negative 
parent–child interactions (23).
Health Care Providers’/Medical Role
Access of the public, children, and their families to healthcare 
providers and to medical research findings are influential fac-
tors in early diagnosis and recognition of ADHD. In the United 
States, the limited access to mental health clinicians results in the 
majority of children being diagnosed and treated by primary care 
physicians (PCP). A study of 60 ADHD patients estimated that 
77.8% of the children diagnosed were treated and followed by a 
PCP and 22.1% were treated and followed by a child psychiatrist 
(24). Limited reimbursement for specialist evaluation or mental 
health care is also a factor in diagnosis of ADHD, particularly for 
complex presentations that may require more clinician time (9). 
There is a marked difference in the frequency of the diagnosis 
between US and European clinicians with this ratio estimated 
to be as high as 20:1, highlighting different clinical approaches, 
thresholds, or medical system factors that influence the diagnosis 
of ADHD (25).
Even when these difficulties of the assessment process do not 
exist, the basic definition of ADHD may pose challenges. There 
are inconsistencies in the definition of ADHD as it is defined in 
the diagnostic and statistical manual disorders-IV-TR or DSM-5 
and in the international statistical classification of disease (21, 
26). The validity and accuracy of ADHD as a diagnosis is still 
questioned by some groups as they dispute the current evidence 
supporting ADHD diagnosis (3, 27). One feature of ADHD 
diagnosis at issue is that it may be easily biased and lacks 
standardization (21), which is in part due to the subjectivity in 
evaluating children with ADHD (28). Also, the decision about the 
threshold of symptoms at which to seek medical attention or at 
which impairment occurs may largely be open to interpretation. 
Research is lacking on objective ways to validate the diagnosis 
(3). Many studies have found that the concordance of the reports 
from different resources like teachers’ report and parents’ evalua-
tions for the same child is poor (28).
However, challenges for clinical diagnosticians can be 
addressed by some methods. Detailed prenatal, family, and edu-
cational histories are of significant value in aiding the diagnosis 
of ADHD (29). When evaluating children for ADHD, questions 
should be asked about ADHD symptoms in siblings and parents 
(23). Parents of children with ADHD are four times more likely 
to have ADHD themselves (30). A study conducted in the United 
States aimed at improving the use of a planned care approach to 
diagnosis reported that out of 60 patients with ADHD, only 5% 
had documentation of standardized diagnostic instruments and 
57% had no documentation of any comorbidity assessment (24). 
Standardized tools of assessment could go far to bolstering the 
accuracy of diagnosis as well as the acceptance by families and 
others of the clinical diagnosis procedure.
educators’ Role
A supportive environment is an essential part of a child’s life. 
Children in the US spend a significant portion of their time in 
school making teachers and the school structure extremely influ-
ential for typical development and for the diagnosis of ADHD.
In clinical assessment of ADHD, a teacher report of a child’s 
behavior is often sought. However, teacher ratings of ADHD 
symptoms in students may have limitations. For example, a 
discrepancy has been shown in the level of reports of ADHD 
symptoms in African American students versus same age non-
black peers (2). Because of the reliance on accurate teacher 
ratings of child behavior, the mental health community makes 
a significant impact when it provides training and support for 
educationally based professionals in the recognition and man-
agement of children with ADHD. These individuals are often 
the first line of recognition due to the amount of time children 
spend in classrooms and the differing levels of demands that can 
reveal children’s need for mental health intervention (31). The 
attitude of schools toward ADHD and their incorporation of early 
intervention efforts can have a significant impact on children and 
parents (32). Many parents express feeling unheard by teachers 
and school administration when concerns were raised about 
symptoms prior to ADHD diagnosis (32).
Children’s Role
Numerous factors intrinsic to a child or youth can affect their 
diagnosis of ADHD including, gender, age, race, socioeconomic 
status, and severity of symptoms (11, 33). While the true rate 
of ADHD in boys is higher than in girls, it is also true that 
detection rates, and therefore formal diagnosis, may differ 
by gender. Boys are more prone to the diagnosis of ADHD 
than girls (10, 23) as they are more likely to present with the 
hyperactive/impulsive or combined type of ADHD, in part due 
to the perception that it is more impairing (12). Clinicians are 
also more likely to give the diagnosis of ADHD to boys when 
compared to girls due to a higher degree of externalizing symp-
toms in males (10, 28). Girls are frequently underdiagnosed as 
they more likely to present with internalizing symptoms (23), 
which can be less apparent, such as forgetfulness and difficulty 
sustaining attention (28).
A thorough work up for ADHD also incorporates assessment 
for common comorbid symptoms/diagnosis, including anxiety, 
depression, oppositional defiant and conduct disorders, devel-
opmental and learning disorders or other neurodevelopmental 
disorders. At times somatic, physical, or syndromic features 
can overshadow ADHD symptoms (9, 34). However, the pres-
ence of comorbidities and their severity can also increase the 
likelihood of service use which may be associated with increased 
rates of accurate diagnosis (31). For example, girls with Turner’s 
syndrome (XO) are more predisposed to ADHD (35) and the 
presence of this syndrome may either add to or detract from 
ADHD diagnosis.
Given the diversity of children in the US, the background 
history/demographics of the child is important in making an 
accurate clinical assessment (19). Children with different back-
grounds or exposures can present with disruptive symptoms that 
resemble ADHD but have a different origin such as trauma from 
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exposure to war or a language barrier from recent immigration 
(19). Children living in a household where English is the primary 
language were four times more likely to be diagnosed with ADHD 
than those in which English is not the primary language (6). The 
psychosocial histories of children and factors contributing to 
behavioral phenotypes may vary considerably, and so determin-
ing etiology of behaviors associated with the diagnosis of ADHD 
may be complex (32).
OBJeCTiviTY OF THe DiAGNOSiS AND 
NeeDeD ReSeARCH iN ADHD
There is an apparent discrepancy between the lack of objective 
methods for the clinical diagnosis of ADHD and recent advance-
ments in genetic, neuroimaging, and other biological assessment 
methods (21). Reliable biomarkers would significantly reduce 
some difficulties of diagnosing ADHD but findings thus far have 
not demonstrated distinctive biomarkers that have high sensitiv-
ity and specificity for ADHD diagnosis.
Strong genetic contributions have been reported for ADHD 
(7, 21, 23). It is documented that genetic influences have also 
been shown to mediate the continuity of ADHD between early 
and middle childhood (2). Studies in model systems also suggest 
that genetic variations may cause dysregulation of dopamine 
signaling and paucity of dopamine release in response to stimuli 
result in hyperactivity and forgetfulness similar to the symptoms 
ADHD (36). Despite these important discoveries about genetic 
risk factors, no specific genetic finding has been identified that 
can aid in diagnosis.
EEG and brain imaging have been investigated as a way to 
support and enhance the diagnosis of ADHD and choices about 
treatment. In a study of 10 children, medication responders 
had less Theta/Alpha and more Beta activity on EEG than non-
medication responders (37). However, the number of subjects 
was small and the findings not specific for these biomarkers as 
well as many others that have been investigated. The behaviors 
associated with ADHD clearly have biological correlates which 
theoretically could be demonstrated through differences in 
functional neuroimaging (32). While research studies have 
demonstrated group differences in neuroimaging outcomes 
between ADHD patients and controls: to date the use of the 
radiological imaging has been limited to research about patho-
physiological mechanisms and does not have a clinical role in 
diagnosis (2).
Some studies have examined the role of environmental factors 
that may predispose an individual to ADHD and thus could be 
helpful as diagnostic factors or indicators of risk. For example, 
exposure to nicotine during human prenatal development has 
been linked with ADHD (38), perhaps mediated through dis-
rupted hippocampal and overall brain development as shown in 
animal models (39). Smoking has also been suggested to have 
effects across multiple generations through maternal passage of 
risk for ADHD to offspring (29). Family smoking history may 
thus take on a larger role in ADHD diagnosis as more research 
elucidates these risks. Another factor sometimes considered in 
the diagnostic process is iron deficiency. Iron plays a substantial 
role in the development of the central nervous system, includ-
ing the dopamine, norepinephrine, and serotonin neurotrans-
mitter systems (40). Iron-deficiency in model systems results 
in changes in dopaminergic signaling (41). In a hypothesized 
“two-hit” type of model, iron deficiency may also interact with 
other disruptions of dopaminergic development resulting in 
ADHD-like phenotypes (42). In children, studies have also 
suggested that iron deficiency anemia alter monoamine neu-
rotransmitters and CNS myelination, which may be related to 
ADHD (41).
Serum ferritin levels have been found to be low in children 
with ADHD (43). Also, brain iron level as measured by MRI was 
low in children with ADHD suggesting the involvement of iron 
deficiency in the pathophysiology of ADHD (44).
Lastly, food additives have been examined for possible roles 
in ADHD. Some studies have found positive associations but 
no causal link between hyperactivity and dietary artificial food 
coloring and sodium benzoate preservative (45). However, other 
studies have suggested no relationship between food additives 
and ADHD (46). Managing or alleviating the symptoms of 
ADHD using nutritional supplements as a strategy has also been 
investigated; a meta-analysis of this work demonstrates that the 
effects of supplementation and/or exclusion are likely small and 
may be restricted to patients with food sensitivities (46). Further 
advances in these areas of research may be relevant for both the 
diagnosis and treatment of ADHD.
Attention Deficit Hyperactivity disorder likely arises from 
multiple changes in biological, psychological, and social domains 
from which many etiologies of small effect, both environmental 
and genetic, interact and result in symptoms (47). This process 
likely gives rise to ADHD differently in multiple kinds of vul-
nerable people (27), which may continue to pose challenges to 
diagnosis.
There is need for more research in child psychiatry at the basic 
biological level, focusing on early human brain development, to 
help better understand the pathophysiology of ADHD and child 
psychiatric illnesses in general (48).
ADHD iN ADOLeSCeNTS AND YOUNG 
ADULTS
Adolescents and youth face challenges during transition to adult-
hood which can limit their abilities to obtain medical services 
(9, 23, 49). During adolescence and young adulthood, only 50.9 
and 28.9%, respectively, of those meeting DSM IV criteria for 
ADHD had received any treatment in the past 3  months (23). 
There are multiple factors that contribute to this decline in 
ADHD treatment that accompanies adulthood. Physician may 
rely more on adolescents reporting their own symptoms at this 
age, as they have less supervision by their parents; however, 
adolescents may minimize their behavioral problems, which can 
lower the probability of receiving an accurate diagnosis of ADHD 
(9). In addition, it is very common for adolescents who received 
a diagnosis in childhood to discontinue medical care over time 
(9). Physicians should obtain previous records of adolescents 
to review prior ADHD symptomology and to evaluate for 
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comorbidities including substance use disorders (SUD), depres-
sion, and anxiety (50).
As ADHD is regarded as a childhood disorder, there is 
much less research about ADHD in adults (51). The worldwide 
prevalence of ADHD in adults is estimated to be 4–5.9% in all 
age groups (51). One study showed that using DSM IV criteria 
for diagnosing adults, which mandates six hyperactive-impulsive 
symptoms excluded almost half of adults who were at least 1.5 
SD above the population mean. DSM-5 has a lower threshold for 
adult diagnosis, mandating four symptoms for diagnosis, which 
could be a more sensitive threshold for detecting individuals with 
functional impairment (26, 52).
CONTROveRSieS SURROUNDiNG THe 
TReATMeNT OF ADHD
Diagnosis with ADHD matters, in part, because it is often accom-
panied by recommendations for treatment. Treatment of ADHD 
has been a source of controversy, especially in relation to the use 
of psychostimulants like methylphenidate (Ritalin) and mixed 
amphetamine salts (Adderall) and non-stimulants, such as ato-
moxetine, clonidine, and guanfacine for children, each of which 
has its own limitations (28, 53, 54). More extensive reviews exist 
that discuss the thresholds for use and limitations of stimulant 
treatment for children with ADHD (55), only some of which will 
be discussed here.
Stimulants used in the treatment of ADHD are thought 
to act by increasing brain catecholamine levels (56) and are 
effective in 65–75% of children after a first stimulant trial (57). 
Methylphenidate blocks dopamine and norepinephrine re-
uptake transporters (58) and has been used for the treatment of 
ADHD for many decades. Despite this long history of use, the 
precise prefrontal cortical and subcortical mechanisms of action 
are poorly understood (56) for both methylphenidate and mixed 
amphetamine salts, which may partially contribute to ongoing 
controversies about their use.
Evidence suggests there has been an increased use of stimu-
lants in US (6, 59, 60). The prevalence of stimulant use in the 
United States estimated to be 4.4–6.1% (6, 61), with a reported 
increase of 28% from 2007 to 2011(6). Another study estimated 
that just over half of the US children with ADHD were treated 
with stimulants (6). This is attributable to multiple factors 
including physician prescribing practices as well as parental 
and child attitudes about ADHD diagnosis and treatment (6, 
11, 56). More clinically related variables that effect adherence to 
recommended stimulant treatment include how the mechanism 
of action of stimulants is explained and how medication rou-
tines are simplified (18, 62). In the popular press, the increased 
call for early diagnosis and treatment of ADHD has been 
attributed at times to profit-seeking actions of pharmaceutical 
companies (54). Others have argued that increased treatment 
of children with severe ADHD has led to benefits including 
decreased number of hospitalizations and decreased crime 
rates (56). Despite observations that stimulant use is increasing, 
epidemiological studies at the National Health and Nutrition 
Examination Survey (NHANES) and the National Comorbidity 
Survey Adolescent Supplement (NCS-A) show that many 
children meeting ADHD criteria do not receive treatment (5). 
Studies suggest that African American and Hispanic children in 
particular have lower prescription filling rates than Caucasian 
children (2, 63). This may be a result of lower percentage of 
diagnosis in these populations or variations in attitudes about 
the treatment of ADHD.
The adverse side effects of stimulant use contribute to the 
ambivalence some patients and families have about treatment 
initiation and compliance (56). Possible side effects include 
insomnia, decreased appetite, headache, increased blood pressure 
and heart rate, symptoms of anxiety and depression, and slowing 
of growth with the possibility that there may be modest sustained 
differences from a child’s anticipated adult height if children 
remain on stimulants for years (28, 56, 64). Some patients may 
benefit from their clinicians becoming more educated about opti-
mizing stimulant use by titrating the medication until achieving 
the maximum benefits (9). The development of novel treatments 
with different side effect profiles may also provide some resolution 
to concerns about adverse effects. Regardless, treatment options 
for ADHD will always inform perceptions of the disorder itself 
and its diagnosis.
Other treatment modalities in addition to pharmacotherapy 
include: educational modifications, behavioral treatments for 
parents and teachers to help children modify behavior, and cog-
nitive enhancement interventions (65). While the evidence base 
for each of these differs, multiple different approaches are used 
widely in the treatment of ADHD. All approaches elicit a variety 
of individual and community opinions that in turn influence 
whether individuals receive an ADHD diagnosis.
CONSeQUeNCeS wHeN ADHD iS NOT 
TReATeD
One of the major consequences of ADHD not being diagnosed 
is a lack of treatment. Untreated ADHD can pose a tremendous 
amount of psychological, financial, academic, and social burden to 
the individual and the community, which reflects the importance 
of diagnosing and treating the disorder (23, 66). While treatment 
has not been shown to completely “normalize” the developmental 
trajectory of individuals with ADHD, individuals with ADHD 
who do not receive treatment have poorer long-term outcomes 
compared to those that are treated (51). Untreated ADHD during 
childhood is a risk factor for later adult mental health issues, which 
extend beyond impairment in academics (66). A lack of treatment 
for ADHD also impairs social and occupational functioning and 
increases the likelihood of developing comorbid disorders like 
anxiety, depression, personality disorders, antisocial behaviors, 
and SUD (66, 67). Many mechanisms may be at work linking 
undiagnosed ADHD to vulnerabilities (27).
The consequences of untreated ADHD has been shown in 
many different domains of functioning.
Academic Achievement
A longitudinal study that examined the impact of stimulant treat-
ment in ADHD to academic outcome during late adolescence 
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found that children treated with stimulants showed academic 
gains on several measures relative to children who did not receive 
treatment (68).
Family/Relationship
Symptoms of hyperactivity that would typically be addressed by 
treatment are linked, when untreated, to long-term social and 
peer problems (69). Poor listening skills and poor frustration 
tolerance that persist in untreated ADHD can lead to tension at 
work and home, decreased intimate relationships, internalizing 
problems, and low self-esteem in adulthood (23). When ADHD 
persists in parenthood, there is an increased risk of family conflict 
and negative parent–child interactions; this may be related to 
parents with ADHD being easily frustrated and unable to control 
their emotions and impulses when untreated (23). A study based 
on a clinical sample also found a connection between childhood 
ADHD and intimate partner violence (IPV) in adulthood in 
association with conduct disorder (CD) and when controlling 
for CD as a comorbidity (70).
Substance/Alcohol Abuse
Much work over the past decades suggests that there is a strong 
link between ADHD and substance/alcohol abuse (23, 66, 71). An 
increase in risk for substance use, nicotine addiction, and alcohol 
abuse was conferred by even a single symptom of hyperactivity 
or inattention (71). While many individuals treated for ADHD 
continue to have persistent symptoms, this study also suggests 
that the initiation of substance use was more likely with more 
uncontrolled symptoms. Having ADHD is associated with an 
earlier onset of psychoactive substance abuse across the life 
course (23). For adolescent boys and girls, increased levels of 
hyperactivity and impulsivity symptoms had a statistically sig-
nificant prediction for all substance abuse, nicotine dependence 
and cannabis abuse, even when controlling for conduct disorder 
as a comorbidity (71).
Links between ADHD and SUD may be bidirectional (66). 
Adults with SUD have been shown to have a higher rate of 
ADHD than the general population and, in this population, 
ADHD contributes to increased rates of comorbid disorders, 
previous criminal convictions and suicide attempts (66). 
Substance using individuals with ADHD compared to those 
with only SUD had higher self-rated impairment across several 
domains of daily life and higher rate of substance abuse and 
alcohol consumption, suicide attempts, and depression. These 
findings highlight the negative impact of ADHD on individuals 
and the increased burden they place on the mental healthcare 
system (66).
Financial/employment
Attention Deficit Hyperactivity disorder, especially when 
untreated, can lead to financial and employment difficulties (8, 
33, 72). Studies suggest that uncontrolled ADHD can negatively 
affect work efficiency leading to longer hours of work, job insta-
bility, lack of insight into future goals, and lower annual personal 
incomes (23, 33). Across 10 national surveys examined in the 
WHO World Mental Health (WMH) Survey Initiative, workers 
with ADHD had significantly more sick days per year and higher 
annualized average excess numbers of workdays associated with 
reduced work quantity and quality (72). Even if some adults are 
able to maintain appearances, overcoming impairments that are 
not treated may be a struggle that can interfere with general life 
satisfaction (23, 73). Procrastination, distractibility, frequent lost 
workdays, and disability have high economic burden with greater 
utilization of medical services (23, 74).
Criminal
Untreated ADHD is associated with higher rates of criminality, 
imprisonment, speeding, traffic violation, and motor vehicle 
accidents (23, 75, 76).
Comorbidity
Longitudinal research that followed hyperactive children for 
10  years has suggested that hyperactivity is a risk factor for 
increases in other psychiatric diagnosis (69). The precise rela-
tionship between CD/ODD and ADHD, especially the mecha-
nism of development of antisocial behavior in children with 
ADHD, is not fully understood. However, aggressive behavior 
which occurs in some children with ADHD, particularly without 
treatment, is highly predictive of whether juvenile offenders will 
reoffend (77).
Mortality
Mortality rate in a recent study of an ADHD population was 
5.85 per 10,000 person-years compared with 2.21 in controls. 
Interestingly, the highest rate of mortality was found in people 
diagnosed in adulthood (78). When diagnosed between 1 and 
5  years, the mortality rate ratio (MRR) for individuals with 
ADHD was 3.34%. For diagnosis between ages 6 and 17, the MRR 
increased to 4.34%, and if ADHD was diagnosed after 17 years of 
age, the MRR is 22.28% (78). This emphasizes the importance of 
early diagnosis and treatment in ADHD. Children with ADHD, 
adolescents in particular, have a significantly higher suicide rate at 
three times higher than the national average. While no evidence 
supports a direct link between untreated ADHD and suicide, the 
increased risk may be conferred by ADHD comorbidities (2). 
Comorbidities like oppositional defiant disorder, conduct disor-
der, and SUD increase the MRR in ADHD and when adjusted for 
these comorbidities, ADHD remains associated with increased 
MRR (78).
CONSeQUeNCeS wHeN ADHD iS NOT 
DiAGNOSeD
Many of these issues surrounding perception of ADHD and 
the ability to effectively assess individuals for ADHD influ-
ence whether or not accurate diagnoses of ADHD are made. 
While there are significant data detailing the consequences of 
ADHD not being treated, fewer studies have been performed to 
understand whether diagnosis matters independently. ADHD 
diagnosis and its associated opportunity for psychoeducation 
and prognostic information may have important effects on 
development.
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The few studies that have been done suggest that there are con-
sequences in a variety of domains. First, evidence suggests lower 
levels of educational attainment in individuals with ADHD who 
are undiagnosed compared to those diagnosed (8, 33, 68). The 
prevalence of undiagnosed ADHD within a substance treatment 
population was approximately fivefold higher than the general 
population (66) suggesting that undiagnosed ADHD may have 
substance abuse requiring treatment as a consequence. The rela-
tive underdiagnosis of ADHD in girls may lead to more women 
gaining an ADHD or other diagnosis in adulthood, with high 
rates of inattentive or impulsive symptoms at times diagnosed as 
depression and borderline personality disorder (23). Undiagnosed 
ADHD subjects are less likely to report that a first-degree family 
member had been diagnosed with ADHD; missed diagnosis 
in parents or sibling can result in missed or delay diagnosis in 
other members of the family (33). Also, as reviewed previously, 
the MRRs of individuals with delayed diagnosis of ADHD has 
been shown to be significantly higher than those diagnosed 
earlier, suggesting that a lack of diagnosis may accumulate risks 
to mortality (78).
THe eXPeRieNCe OF HAviNG THe 
DiAGNOSiS OF ADHD
Several studies have focused on examining the experience 
described by individuals with ADHD. Understanding the emo-
tional and psychological burden of this diagnosis and its impact 
in a child or youth’s quality of life and well-being may help to 
inform controversies about diagnosis and the basic perception 
of ADHD.
Having ADHD has been shown in multiple studies to be a 
source of stress, with some individuals recalling a constellation 
of feelings of loneliness, isolation, low self-esteem, and struggle 
to get along with their parents and peers at school (32, 79, 80). 
Despite struggles related to ADHD symptoms, receiving the 
diagnosis does not always reduce stress for an individual. Some 
individuals have described perceiving a certain degree of stigma 
attached to being diagnosed with ADHD, influencing their will-
ingness to disclose their diagnosis to other people. Additionally, 
others have reported feeling that ADHD is viewed by others as 
a “convenient excuse” for their behavioral problems and they 
may be labeled as a “problem person” rather than a person who 
has a problem (79, 80). At times, ADHD diagnosis led young 
people to feel hurt by their peers when they were teased or 
targeted because of their apparent academic delay and labeled as 
“retarded” (79). Some perceived their identity was challenged by 
a diagnosis of ADHD and also felt less in-control of their lives, 
especially when faced with the prospect of taking medication 
for life (32). Still other individuals report having the diagnosis 
of ADHD lead them to feel as though they were different and 
isolated (79).
On the other hand, some individuals have described that the 
extra attention from their teachers or parents that accompanied 
the diagnosis of ADHD helped affirm and build confidence (79, 
80). A qualitative study in which participants described their 
experience in their own words classified the psychological impact 
of receiving the diagnosis of ADHD into different emotional 
stages of psychological acceptance including both positive and 
negative aspects: (a) relief and optimism, (b) denial, (c) anger and 
resentment, (d) grief, (e) mobilization, and (f) accommodation 
(32). Individuals diagnosed late reported low self-esteem and 
underachievement due to repetitive experiences of failure during 
childhood (80). Clearly, ADHD diagnosis during childhood or 
adolescence has mixed consequences psychologically for young 
people.
CONCLUSiON
We have reviewed many of the complexities that lead to and arise 
from the diagnosis of ADHD. One of the key conclusions from 
this body of literature is that receiving the diagnosis of ADHD 
may benefit individuals by creating the possibility for treatment. 
A significant body of research has demonstrated that treatment 
is strongly associated with improved outcomes. Outcomes after 
receiving an ADHD diagnosis independent of treatment are not 
well understood; however, significant psychological effects of 
receiving a diagnosis have been described. These latter findings 
are in line with the complex experience clinicians have as they 
partner with children, youth and families coping with behavioral 
problems. It is precisely this partnership that then takes on 
greater significance when faced with such a double-edged sword 
in diagnosing and treating ADHD. Medical knowledge about 
the benefits of treating ADHD, together with the concern that 
clinicians feel for their patients’ long-term success, will hope-
fully reduce barriers to diagnosis in the future. This may be 
accomplished through psychoeducation, greater communication 
between clinicians, parents, and educators, and more research on 
biomarkers. Although barriers exist, clinicians who truly partner 
with their patients also understand that individuals receiving 
an ADHD diagnosis may experience immediate and complex 
emotions as well as challenges to their identity. The process of 
diagnosing ADHD is not unlike the diagnosis of other chronic 
and serious medical conditions and thus can benefit positively 
from the medical perspective. This perspective has the potential 
to positively impact the entire life course of individuals with 
ADHD as well as their families. The partnership between clini-
cian and patient is one of the most important ways in which this 
benefit can arise.
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